Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Go back to Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 324.10 +0.35 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.75 | 52 Week High | $141.32 | |||
| Open | $320.20 | 52 Week Low | $97.79 | |||
| Day High | $331.71 | P/E | 51.86 | |||
| Day Low | $314.78 | EPS | $6.25 | |||
| Volume | 440,954 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.66 +0.09 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $45.34 | |||
| Open | $5.57 | 52 Week Low | $15.92 | |||
| Day High | $5.74 | P/E | 2.43 | |||
| Day Low | $5.39 | EPS | $2.33 | |||
| Volume | 1,964,856 | |||||



